Furthermore, our presented findings suggest that NSUN2 promotes tumor growth and metastasis by increasing ALYREF/YBX1-mediated YAP expression in NSCLC and effective inhibition of m<sup>5</sup>C modification might provide a potential treatment strategy for NSCLC. The gene discussed is ALYREF; the disease is non-small cell lung carcinoma.